Do all Melanoma respond to Immunotherapy?
In a study published this week in the New England Journal of Medicine, which was funded by the National Cancer
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
In a study published this week in the New England Journal of Medicine, which was funded by the National Cancer
Read more(By Ed Silverman for ST A T) Thanks to a pair of pricey hepatitis C treatments, Gilead Sciences has become
Read more(By Ed Silverman for ST A T) A t a meeting held last week to review the opioid epidemic, FDA
Read more(By Damian Garde for ST A T) F ederal regulators on Tuesday gave Juno Therapeutics the all-clear to resume testing
Read more(By Meghana Keshavan for ST A T) A n experimental drug touted as a breakthrough for treating severe postpartum depression
Read moreThe one key player in health care that escaped upheaval of Obamacare was the drug industry. With prescription drugs being
Read more(By Ed Silverman for ST A T) T he “Right to Try” movement may be embedded in the Republican Party
Read more(By Ed Silverman for ST A T) I n its latest to bid to set parameters around compounding, the US
Read more(By Scott Gottlieb and Kavita Patel for Health Affairs Blog posted July 11, 2016) As the biological basis of more
Read more(By Julie Rovner and Francis Ying for Kaiser Health News) This is the second in a series of videos about
Read more